Tunstall Partners with NHS Gloucestershire in Clinically-led Long Term Conditions Management Programme

Tunstall HealthcareTunstall Healthcare has partnered with NHS Gloucestershire, the primary care trust for Gloucestershire, to implement a large-scale telehealth programme to support the management of long term conditions.

This large-scale telehealth programme aims to provide a managed system of care and response, targeted at patients with long term conditions for whom a timely response will help manage their short and medium term care needs, therefore improving patient outcomes and helping reduce the number of hospital admissions.

Gloucestershire has a population of more than 600,000 people with approximately 6,000 of those people living with a long-term condition (LTC). The use of telehealth complements the changing nature of healthcare to provide care in the right place at the right time and, having run a small scale initiative, NHS Gloucestershire is keen to tap into the expertise of Tunstall to roll out a much larger project to support local people.

The partnership will see Tunstall work with local clinicians across both secondary and primary care to redesign care pathways and implement clinical protocols which will see telehealth as a viable option for managing patients.

As part of the programme, the provision of telehealth will be extended to 2,000 patients with chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), chronic heart disease (CHD) and diabetes.

Dr Will Haynes, a Gloucester-based GP and practice-based commissioning lead for Gloucester who is working closely with Tunstall on this project, said: "The widespread use of telehealth technology will complement other developments across the NHS in Gloucestershire to help reduce referrals to hospitals, help more patients to receive their care within, or as close to, home as possible and help more patients to understand better and self manage their own conditions, within the safety and fabric of telehealth monitoring. As a GP, I welcome the opportunity to use these tools to work with patients to understand their condition."

The provision of telehealth will be extended over a 12-month period commencing in Summer 2011, following a comprehensive, clinically-led development process with Tunstall and Ernst & Young providing full project management and a detailed care pathway redesign programme.

Jon Lowe, Tunstall's Managing Director said: "We are extremely pleased to be working in a strategic partnership with such an innovative team. We are committed to ensuring this large-scale managed telehealth service is a success and I am confident that patients and clinicians will benefit greatly in the future."

Related news articles:

About Tunstall
Tunstall Healthcare Group is the market-leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall’s solutions support older people and those with long-term needs, to live independently, by effectively managing their health and well-being. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...